DE69609868D1 - Neue steroidester zur behandlung von hauterkrankungen - Google Patents

Neue steroidester zur behandlung von hauterkrankungen

Info

Publication number
DE69609868D1
DE69609868D1 DE69609868T DE69609868T DE69609868D1 DE 69609868 D1 DE69609868 D1 DE 69609868D1 DE 69609868 T DE69609868 T DE 69609868T DE 69609868 T DE69609868 T DE 69609868T DE 69609868 D1 DE69609868 D1 DE 69609868D1
Authority
DE
Germany
Prior art keywords
steroidesters
new
skin diseases
treating skin
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69609868T
Other languages
English (en)
Other versions
DE69609868T2 (de
Inventor
Joseph Gubernick
H Maes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Estee Lauder Inc
Original Assignee
Estee Lauder Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Estee Lauder Inc filed Critical Estee Lauder Inc
Publication of DE69609868D1 publication Critical patent/DE69609868D1/de
Application granted granted Critical
Publication of DE69609868T2 publication Critical patent/DE69609868T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
DE69609868T 1995-09-12 1996-09-05 Neue steroidester zur behandlung von hauterkrankungen Expired - Fee Related DE69609868T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/527,145 US5736537A (en) 1995-09-12 1995-09-12 Dehydroep:androsterone sailcylate useful against skin atrophy
PCT/US1996/014247 WO1997010255A1 (en) 1995-09-12 1996-09-05 Novel steroid esters useful against skin disorders

Publications (2)

Publication Number Publication Date
DE69609868D1 true DE69609868D1 (de) 2000-09-21
DE69609868T2 DE69609868T2 (de) 2001-03-15

Family

ID=24100286

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69609868T Expired - Fee Related DE69609868T2 (de) 1995-09-12 1996-09-05 Neue steroidester zur behandlung von hauterkrankungen

Country Status (13)

Country Link
US (3) US5736537A (de)
EP (1) EP0876391B1 (de)
AR (1) AR004683A1 (de)
AT (1) ATE195527T1 (de)
AU (1) AU712977B2 (de)
CA (1) CA2231781C (de)
CO (1) CO4770981A1 (de)
DE (1) DE69609868T2 (de)
ES (1) ES2151180T3 (de)
HK (1) HK1015794A1 (de)
IL (1) IL123637A (de)
WO (1) WO1997010255A1 (de)
ZA (1) ZA967704B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736537A (en) 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
EP0908183A1 (de) * 1997-10-08 1999-04-14 Institute For Advanced Skin Research Inc. Dehydroepiandrosterone oder ihre Derivate zur Erhöhung des Hyaluronische Saüre-Gehalts der Haut
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
KR100302372B1 (ko) * 1998-07-24 2001-12-05 박상철 골다공증예방및치료제로서의디히드로에피안드로스테론유도체
EP1054677B1 (de) * 1998-11-19 2008-10-22 Connective Tissue Imagineering LLC Kosmetische oder dermatologische verwendung von 7-hydroxylierten steroiden aleine oder zusammen mit von elastin abgeleiteten peptiden
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
CA2669753C (en) 1999-09-30 2012-06-26 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
FR2799645B1 (fr) * 1999-10-13 2004-04-30 Oreal Utilisation de la dhea ou de ses precurseurs ou derives metaboliques comme depigmentant
FR2803514B1 (fr) * 1999-10-13 2004-05-21 Oreal Compostion, notamment cosmetique, renfermant un steroide et un filtre uv liposoluble
FR2803513B1 (fr) * 2000-01-12 2003-12-19 Oreal Utilisation de la dhea et/ou de ses precurseurs ou derives pour ameliorer l'aspect papyrace de la peau
FR2803751B1 (fr) * 2000-01-17 2004-03-12 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone,de ses precurseurs et de ses derives comme agents hydratants a action directe
FR2803750B1 (fr) * 2000-01-17 2004-04-02 Assist Publ Hopitaux De Paris Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant
DE10007277A1 (de) * 2000-02-17 2001-10-11 Juergen Thudium Kajal-Eye-Liner zur Warzenentfernung
FR2807323A1 (fr) * 2000-04-10 2001-10-12 Oreal Composition, notamment cosmetique, renfermant un steroide et un 2-alkyl alcanol ou un ester
FR2808683B1 (fr) * 2000-05-15 2003-05-23 Oreal Utilisation de la dhea et/ou ses precurseurs et derives chimiques et/ou biologiques, dans une composition notamment cosmetique, pour prevenir ou traiter l'atrophie de l'epiderme
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
FR2811567B1 (fr) * 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un inhibiteur de no-synthase
FR2811561B1 (fr) * 2000-07-13 2003-03-21 Oreal Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
US6399085B1 (en) * 2001-03-05 2002-06-04 Humanetics Corporation Method of moisturizing the skin by the topical application of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof
US6399084B1 (en) * 2001-03-05 2002-06-04 Humanetics Corporation Method for diminishing wrinkles and fine lines of the skin by the topical application of Δ5-androstene-3β-ol-7, 17 dione and metabolizable precursors thereof
WO2002096374A2 (en) * 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
DE60231272D1 (de) * 2001-06-26 2009-04-09 Oreal Zusammensetzungen, die eine wenig lösliche Verbindung und ein lipophiles Aminosäurederivat enthalten, und entsprechende Verwendungen und Verfahren
FR2826272B1 (fr) * 2001-06-26 2005-02-18 Oreal Composition contenant de la dhea ou un derive de la dhea et un derive lipophile d'acide amine
EP1421940A4 (de) * 2001-08-09 2006-02-08 Sekisui Chemical Co Ltd Medizinische zusammensetzung für die topische anwendung bei dermatosis
FR2832928B1 (fr) * 2001-11-30 2004-02-06 Dermo Cosmologie Lab De Composition a base d'ester de diosgenine applicable par voie topique
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
FR2847467B1 (fr) * 2002-11-25 2006-05-26 Oreal UTILISATION D'UN AGENT MODULATEUR DE L'ACTIVITE DE L'OXYSTEROL 7alpha-HYDROXYLASE POUR LE TRAITEMENT COSMETIQUE DE DESORDRES CUTANES
FR2853318A1 (fr) * 2003-04-07 2004-10-08 Mayoly Spindler Nouveaux procedes de preparation de derives de la dhea
TW200522932A (en) * 2003-09-15 2005-07-16 Combinatorx Inc Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
BRPI0517950A (pt) * 2004-11-01 2008-10-21 Endorech Inc uso de andrógenos para reduzir a probabilidade de adquirir ou para o tratamento do envelhecimento da pele
CN100415709C (zh) * 2006-05-15 2008-09-03 西北大学 β-(3,4-二羟基苯基)-α-羟基丙酸冰片酯、其合成方法和用途
EP2262469A4 (de) * 2008-04-15 2013-12-04 Immanence Integrale Dermo Correction Inc Hautpflegezusammensetzungen und verfahren zu ihrer verwendung
FR2931064B1 (fr) 2008-05-14 2010-08-13 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un derive de pyrrolidinone; procede de photostabilisation du derive de dibenzoylmethane
FR2939309B1 (fr) 2008-12-08 2010-12-17 Oreal Utilisation d'un derive ester de 2-pyrrolidinone 4-carboxy comme solvant dans les compositions cosmetiques ; compositions cosmetiques les contenant
FR2939799B1 (fr) 2008-12-11 2011-03-11 Sederma Sa Composition cosmetique comprenant des oligoglucuronanes acetyles.
EP2382231A2 (de) 2009-01-16 2011-11-02 Sederma Neue verbindungen, insbesondere peptide, zusammensetzungen damit und kosmetische und dermopharmazeutische verwendungen
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2944435B1 (fr) 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
FR2972346B1 (fr) 2011-03-09 2013-11-08 Oreal Utilisation d'un derive diester d'acide 2-methyl succinique comme solvant dans les compositions cosmetiques ; compositions cosmetiques les contenant
WO2012134446A1 (en) * 2011-03-29 2012-10-04 SUTTER WEST BAY HOSPITALS doing business as CALIFORNIA PACIFIC MEDICAL CENTER Epiandrosterone and/or androsterone derivatives and method of use thereof
FR2996133B1 (fr) 2012-10-02 2015-06-26 Oreal Nouvelles utilisations cosmetiques de polymeres dispersants en association avec au moins un actif
JP2016521544A (ja) 2013-05-21 2016-07-25 ドクター レディズ ラボラトリーズ リミテッド デヒドロエピアンドロステロンおよびその中間体の調製法。
EP3057667B1 (de) 2013-10-15 2020-03-04 CHelac Holding GmbH Steroid-carbonsäureester, zusammensetzungen, enthaltend steroid-carbonsäureester und verwendung dieser bei lokal topischer applikation für kosmetische oder dermatologische zwecke
US20160362442A1 (en) * 2015-06-10 2016-12-15 IronMag Labs Method For DHEA Enanthate Processing
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788897A (fr) * 1971-09-17 1973-03-15 Schering Ag Medicament a base d'esters de dehydroepiandrosterone
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US3984566A (en) * 1974-02-25 1976-10-05 Scott Eugene J Van Method of alleviating the symptoms of dandruff
US3988470A (en) * 1974-02-25 1976-10-26 Scott Eugene J Van Treatment of palmar and plant disturbed keratosis
US4105782A (en) * 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
US4380549A (en) * 1975-07-23 1983-04-19 Scott Eugene J Van Topical treatment of dry skin
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4197316A (en) * 1975-07-23 1980-04-08 Scott Eugene J Van Treatment of dry skin
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
DE2656015A1 (de) * 1976-12-10 1978-06-15 Bbc Brown Boveri & Cie Verfahren zum herstellen von halbleiterbauelementen
US4194007A (en) * 1978-01-13 1980-03-18 Scott Eugene J Van α-Hydroxyretinoic acid, α-ketoretinoic acid and mixtures and their use in treating skin conditions
US4234599A (en) * 1978-10-04 1980-11-18 Scott Eugene J Van Treatment of skin keratoses with α-hydroxy acids and related compounds
US4246261A (en) * 1979-08-09 1981-01-20 Scott Eugene J Van Additives enhancing topical corticosteroid action
US4542129A (en) * 1982-08-16 1985-09-17 Norman Orentreich DHEA Formulations and methods for treating dry skin
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
AU582122B2 (en) * 1983-08-02 1989-03-16 Research Corporation Steroids useful as anti-cancer,anti-obesity, anti-hyperglycemic,anti-autoimmune and anti-hyperchlesterolemic agents
JPS60161912A (ja) * 1984-02-01 1985-08-23 Kanebo Ltd 皮膚化粧料
US4628052A (en) * 1985-05-28 1986-12-09 Peat Raymond F Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
EP0210665B1 (de) * 1985-08-02 1989-10-18 Research Corporation Steroide zur Verwendung als Mittel gegen Krebs, Fettsucht, Hyperglyzemie, autoimmune Krankheit und Hypercholesterolemie
EP0230574A3 (de) * 1986-01-31 1989-03-22 Yale University Pharmazeutische Zusammensetzungen gegen durch LAV/HTLV-III-Virus verursachte Infektionen und ihre Verwendung
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
DE3862405D1 (de) * 1987-03-09 1991-05-23 Alza Corp Zusammensetzung zur vorbeugung einer kontaktallergie durch gleichzeitiges verabreichen eines kortikosteroids mit einem sensiblisierenden arzneistoff.
NL194728C (nl) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
JPS6440428A (en) * 1987-08-07 1989-02-10 Daiichi Yakuhin Sangyo Kk Antihyperlipemia
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5028631A (en) * 1987-11-25 1991-07-02 Schwartz Arthur G Homoandrostan-17-one and homoandrosten-17-ones
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
EP0396686B1 (de) * 1988-11-03 1994-06-22 Ascom Tech Ag Verfahren und vorrichtung zum dezentralen aussenden von information auf eine übertragungsstrecke
US5262407A (en) * 1988-12-16 1993-11-16 L'oreal Use of salicylic derivatives for the treatment of skin aging
US4920115A (en) * 1988-12-28 1990-04-24 Virginia Commonwealth University Method of lowering LDL cholesterol in blood
US5407684A (en) * 1988-12-30 1995-04-18 Virginia Commonwealth University Use of DHEA as a medicinal
US5077284A (en) * 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response
US5518725A (en) * 1989-09-25 1996-05-21 University Of Utah Research Foundation Vaccine compositions and method for induction of mucosal immune response via systemic vaccination
CA2066716A1 (en) * 1989-09-25 1991-03-26 Raymond A. Daynes Use of steroid hormones in compositions for inducing t cell lymphokine production
US5110810A (en) * 1991-02-08 1992-05-05 Virginia Commonwealth University Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of platelet aggregation
US5162198A (en) * 1991-02-08 1992-11-10 Virginia Commonwealth University Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of thrombuxane production and platelet aggregation
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
US5206008A (en) * 1991-04-15 1993-04-27 Virginia Commonwealth University Enhancement of immune response
WO1993010756A1 (en) * 1991-11-25 1993-06-10 Richardson-Vicks, Inc. Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
WO1993021771A1 (en) * 1992-05-01 1993-11-11 University Of Utah Compositions and methods for regulating il-6 production in vivo
EP0688220B1 (de) * 1993-03-09 2004-11-24 University of Utah Research Foundation Verwendung von dhea oder dessen derivate zur herstellung eines medikaments zur vorbeugung von progressiver gewebe-nekrose, reperfusionsschädigung, bakterieller translokation und vom atemnotsyndrom bei erwachsenen
US5387583A (en) * 1993-04-20 1995-02-07 Loria; Roger M. Compositions containing corticosteroids or analogues thereof and corticosteroid buffering effective amounts of 5-androstene 3B, 17B or 5-androstene 3B, 7B, 17B triol or analogues thereof
US5736537A (en) 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy

Also Published As

Publication number Publication date
HK1015794A1 (en) 1999-10-22
AU6966996A (en) 1997-04-01
ATE195527T1 (de) 2000-09-15
CO4770981A1 (es) 1999-04-30
US5736537A (en) 1998-04-07
ZA967704B (en) 1997-05-27
AU712977B2 (en) 1999-11-18
CA2231781C (en) 2005-07-12
CA2231781A1 (en) 1997-03-20
EP0876391B1 (de) 2000-08-16
EP0876391A4 (de) 1998-12-30
US6025347A (en) 2000-02-15
IL123637A (en) 2003-03-12
AR004683A1 (es) 1999-03-10
IL123637A0 (en) 1998-10-30
ES2151180T3 (es) 2000-12-16
EP0876391A1 (de) 1998-11-11
WO1997010255A1 (en) 1997-03-20
US6284750B1 (en) 2001-09-04
DE69609868T2 (de) 2001-03-15

Similar Documents

Publication Publication Date Title
DE69609868T2 (de) Neue steroidester zur behandlung von hauterkrankungen
ATE200863T1 (de) Indolinonverbindungen zur behandlung von krankheiten
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE59711321D1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
DE69939058D1 (de) Vorrichtung zur behandlung von peripheren gefässerkrankungen
DE69722681D1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE69636674D1 (de) Vorrichtung zur wärmebehandlung von gewebe
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69524682T2 (de) Mittel zur Behandlung von Wunden
DE69525473T2 (de) Vorrichtung zur behandlung von blutgefässen
DE69500089D1 (de) Behandlung von Geflügel
ATA76995A (de) Stabiles präparat zur behandlung von blutgerinnungsstörungen
DE69918687D1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69630321D1 (de) Vorrichtung zur örtlichen wärmebehandlung von gewebe
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69613386T2 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE69506019D1 (de) Vorrichtung zur Behandlung von Schmerz
DE59707519D1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69621447D1 (de) Verwendung von nitroflavonoide zur behandlung von angstzuständen
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee